Purchases and Sales Made in Q1 2022 in Ambrx Biopharma Inc. (AMAM)
This table provides information about the institutional ownership of Ambrx Biopharma Inc. (AMAM) during Q1 2022. The information is specifically focused on institutions that hold shares of Ambrx Biopharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2022
Q1 2022
|
Suvretta Capital Management, LLC
New York, NY |
BUY
|
- |
434K+ 41.04% |
$1.77M - $3.91M
|
1.49M
$41.8M
|
|
|
May 16, 2022
Q1 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
BUY
|
- |
104K+ 5.38% |
$422K - $932K
|
2.03M
$56.8M
|
|
|
May 12, 2023
Q1 2022
|
Norges Bank
Oslo, Q8 |
BUY
|
- |
70KNew |
$285K - $630K
|
70K
$1.96M
|
|
|
May 13, 2022
Q1 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
10.8K+ 91.53% |
$44K - $97.2K
|
22.6K
$633K
|
|
|
Oct 27, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
2.8KNew |
$11.4K - $25.2K
|
2.8K
$78.4K
|
|
|
May 16, 2022
Q1 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
110+ 83.97% |
$448 - $990
|
241
$6.75K
|
|
|
May 09, 2022
Q1 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 02, 2022
Q1 2022
|
Migdal Insurance & Financial Holdings Ltd.
|
SELL
|
- |
-124Closed |
$505 - $1.12K
|
0
$0
|
|
|
May 13, 2022
Q1 2022
|
Caas Capital Management LP
New York, NY |
SELL
|
- |
-13.1KClosed |
$53.2K - $118K
|
0
$0
|
|
|
May 12, 2022
Q1 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-18K- 0.63% |
$73.3K - $162K
|
2.85M
$79.8M
|
|
|
May 09, 2022
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-70KClosed |
$285K - $630K
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-187K- 55.65% |
$763K - $1.69M
|
149K
$4.18M
|